A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Skin on Improving Acne Symptoms and Skin Repair Among Healthy Adults

Exclusion Criteria

• •1. Individuals who are pregnant, breast feeding, or planning to become pregnant during the study
• •2. Self-reported allergy, sensitivity or intolerance to investigational product or placebo ingredients, including allergy to salicylic acid or any form of salicylates, preventing topical use
• •3. Individuals with significant facial hair that would impede the visualization of facial acne and may interfere with the use of the product, such as beards and long sideburns, as assessed by the QI
• •4. Self-reported psoriasis, dermatitis, vitiligo, or any other active dermatological condition other than acne affecting the face
• •5. Self-reported use of topical products on the face marked with claims relating to skin health, or those with claims relating to acne during the study, except for noncomedogenic moisturizers and sunscreen
• •6. Self-reported shaving, waxing, tweezing, or threading of the face or use of nose/facial strips within 3 days prior to each photo capture
• •7. Procedures such as microdermabrasion, peels, acne treatments, filler, botulinum toxin, red light therapy, pore suction therapy, or laser on the face within three months of baseline
• •8. Self-reported UVA or UVB exposure to the face in the past two weeks or expected during the study to avoid sunburn.
• •9. Current use of prescribed and/or over-the-counter (OTC) medications, supplements, and/or consumption of food/drinks that may impact the efficacy and/or safety of the investigational product (Sections 7.3.1 and 7.3.2)
• •10. Self-reported asthma
• •11. Self-reported presence of a peptic ulcer
• •12. Self-reported autoimmune disease or are immune compromised
• •13. Self-reported ongoing and unstable diseases/conditions in the past three months, including:
• •1. Arthritis and joint diseases
• •2. Gastrointestinal diseases
• •3. Hypertension
• •4. Type I or type II diabetes
• •5. Cardiovascular disease
• •6. Kidney diseases
• •7. Liver diseases
• •8. Thyroid condition
• •9. Psychiatric conditions
• •14. Major surgery in the past 3 months or individuals who have planned surgery during the course of the study
• •15. Cancer, except skin basal cell carcinoma completely excised with no chemotherapy or radiation with a follow up that is negative. Volunteers with cancer in full remission for more than five years after diagnosis are acceptable
• •16. Alcohol intake average of \>2 standard drinks per day
• •17. Alcohol or drug abuse within the last 12 months
• •18. Participation in other clinical research studies 30 days prior to screening
• •19. Individuals who are unable to give informed consent
• •20. Any other condition or lifestyle factor that may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant